Sparsh Bio-tech Private Limited — Ampicillin Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ampicillin · $10.4M export value · DGFT Verified
Sparsh Bio-tech Private Limited is the #3 Indian exporter of Ampicillin with $10.4M in export value and 209 verified shipments. Sparsh Bio-tech Private Limited holds a 7.3% market share in Ampicillin exports across 3 countries. The company exports 2 pharmaceutical products worth $17.0M across 1 therapeutic categories.
Sparsh Bio-tech Private Limited — Ampicillin Export Profile: Buyers & Destinations
Where Does Sparsh Bio-tech Private Limited Export Ampicillin?
Sparsh Bio-tech Private Limited exports Ampicillin to 3 countries. The largest destination is TANZANIA accounting for 73.0% of Sparsh Bio-tech Private Limited's Ampicillin shipments, followed by KENYA (25.7%) and MYANMAR (1.3%). These destinations reflect Sparsh Bio-tech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ampicillin from Sparsh Bio-tech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SPARSH BIO-TECH HEALTHCARE PVT LTD | TANZANIA | $1.3M | 60 |
| TO THE ORDER OF THE BANK OF AFRICA | TANZANIA | $897.5K | 20 |
| TO THE ORDER OF ABSA BANK UGANDA | KENYA | $882.2K | 26 |
| SPARSH BIO-TECH HEALTHCARE PVT. LTD | TANZANIA | $633.1K | 13 |
| SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED | TANZANIA | $582.0K | 25 |
| TO THE ORDER | KENYA | $372.5K | 12 |
| M/S. KENTONS LIMITED | KENYA | $194.9K | 7 |
| TO THE ORDER OF ECOBANK TANZANIA | TANZANIA | $186.8K | 5 |
| SAFINA PHARMACEUTICALS LTD | TANZANIA | $183.3K | 24 |
| JEET PHARMACY T LIMITED | TANZANIA | $150.0K | 3 |
Sparsh Bio-tech Private Limited supplies Ampicillin to 19 buyers globally. The largest buyer is SPARSH BIO-TECH HEALTHCARE PVT LTD (TANZANIA), followed by TO THE ORDER OF THE BANK OF AFRICA (TANZANIA) and TO THE ORDER OF ABSA BANK UGANDA (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ampicillin Export Value and How Much Does Sparsh Bio-tech Private Limited Contribute?
India exported $52.7M worth of Ampicillin through 4,470 shipments from 486 suppliers to 133 countries, serving 924 buyers globally. Sparsh Bio-tech Private Limited contributes $10.4M to this total, accounting for 7.3% of India's Ampicillin exports. Sparsh Bio-tech Private Limited ships Ampicillin to 3 countries through 19 buyers.
What Is the Average Shipment Value for Sparsh Bio-tech Private Limited's Ampicillin Exports?
Sparsh Bio-tech Private Limited's average Ampicillin shipment value is $50.0K per consignment, based on 209 shipments totaling $10.4M. The largest destination is TANZANIA (73.0% of Sparsh Bio-tech Private Limited's Ampicillin exports).
How Does Sparsh Bio-tech Private Limited Compare to Other Indian Ampicillin Exporters?
Sparsh Bio-tech Private Limited ranks #3 among 486 Indian Ampicillin exporters with a 7.3% market share. The top 3 exporters are STERISCIENCE SPECIALTIES PRIVATE LIMITED ($12.9M), SPARSH BIO-TECH PRIVATE LIMITED ($10.4M), AUROBINDO PHARMA LTD ($4.7M). Sparsh Bio-tech Private Limited processed 209 shipments to 3 destination countries.
What Ampicillin Formulations Does Sparsh Bio-tech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMPICILLIN AND CLOXACILLIN CAPSULES 500 | $1.4M | 30 |
| AMPICILLIN AND CLOXACILLIN ORAL SUSPENSI | $587.1K | 21 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 4146.870 KGS / PRICEPER KG 43.00292 USDPCS | $300.0K | 6 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 5529.160 KGS / PRICEPER KG 45.34985 USDPCS | $150.0K | 3 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 6220.305 KGS / PRICEPER KG 42.27405 USDPCS | $150.0K | 3 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG TOTAL NET WEIGHT - 5531.160 KGS / PRICE PER KG 42.98737 USD | $150.0K | 3 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG TOTAL NET WEIGHT - 3453.667 KGS / PRICE PER KG 42.56560 USD | $141.1K | 3 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG Total Net Weight - 4146.802 kgs / Price Per kg 43.73177 USD | $100.0K | 2 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 4146.870 KGS / PRICEPER KG 45.37901 USD | $100.0K | 2 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500MGTotal Net Weight - 2748.528 kgs / PricePer kg 41.37026 USD | $100.0K | 2 |
Sparsh Bio-tech Private Limited exports 95 distinct Ampicillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMPICILLIN AND CLOXACILLIN CAPSULES 500 with 30 shipments worth $1.4M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Sparsh Bio-tech Private Limited Compare to Nearest Ampicillin Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $12.9M | 259 | 3 | $50.0K |
| 3 | SPARSH BIO-TECH PRIVATE LIMITED ★ | $10.4M | 209 | 3 | $50.0K |
| 6 | AUROBINDO PHARMA LTD | $4.7M | 106 | 10 | $44.1K |
| 7 | MEDREICH LIMITED | $4.1M | 102 | 5 | $40.6K |
Sparsh Bio-tech Private Limited ranks #3 among 486 Indian Ampicillin exporters. Average shipment value of $50.0K compared to the market average of $108.4K. The closest competitors by value are STERISCIENCE SPECIALTIES PRIVATE LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Ampicillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 412 | 9.2% |
| DELHI AIR CARGO ACC (INDEL4) | 317 | 7.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 6.7% |
| SAHAR AIR | 259 | 5.8% |
| DELHI AIR | 233 | 5.2% |
| BANGALORE ICD | 226 | 5.1% |
| MUNDRA SEA | 205 | 4.6% |
| JNPT/ NHAVA SHEVA SEA | 204 | 4.6% |
What Other Antibiotics Products Does Sparsh Bio-tech Private Limited Export?
Sparsh Bio-tech Private Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Sparsh Bio-tech Private Limited's Ampicillin Exports
The current geopolitical climate presents significant challenges for Indian pharmaceutical exporters like Sparsh Bio-tech. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter key trade routes, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes (livemint.com). This disruption is particularly concerning for time-sensitive shipments, such as pharmaceuticals, where delays can compromise product efficacy and safety.
Additionally, the U.S. has imposed tariffs on pharmaceutical imports, including those from India, as part of broader trade policies (pubtexto.com). These tariffs could erode the price competitiveness of Indian exporters like Sparsh Bio-tech in the U.S. market. Furthermore, the European Union's implementation of the Falsified Medicines Directive (FMD) imposes stringent serialization and traceability requirements. Compliance with these regulations necessitates significant investment in technology and processes, potentially straining resources for companies with limited product portfolios.
Sparsh Bio-tech Private Limited — Regulatory Compliance & Quality Standards
For Indian pharmaceutical exporters, adherence to international regulatory standards is paramount. Compliance with the U.S. Food and Drug Administration (FDA), the World Health Organization's Good Manufacturing Practices (WHO GMP), and the European Union's regulations is essential for market access. While specific compliance records for Sparsh Bio-tech are not publicly available, the company's focused product line may facilitate streamlined quality control processes. However, any lapses in compliance could have disproportionate effects, given the company's reliance on a narrow product range.
About Sparsh Bio-tech Private Limited
Sparsh Bio-tech Private Limited exports 2 products worth $17.0M. Beyond Ampicillin, top products include Amoxicillin. View the complete Sparsh Bio-tech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ampicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ampicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sparsh Bio-tech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 218 individual customs records matching Sparsh Bio-tech Private Limited exporting Ampicillin, covering 95 formulations to 3 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 924+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ampicillin Export Data from Sparsh Bio-tech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sparsh Bio-tech Private Limited's Ampicillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sparsh Bio-tech Private Limited
Full Company Profile →
2 products · $17.0M total trade · 1 categories
Ampicillin Stats
Company Overview
Top Products by Sparsh Bio-tech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sparsh Bio-tech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ampicillin. For current shipment-level data, contact TransData Nexus.